TB-500 10mg

TB-500 is a research-catalogue name associated with thymosin beta-4 (Tβ4). Tβ4 binds actin, a protein that forms part of the cell’s internal structure, and has been studied for its role in actin assembly and cell movement.

The name TB-500 is used inconsistently for full-length Tβ4 and shorter fragments. Check the identity reported for the specific batch rather than assuming every TB-500 listing is chemically identical.

Sources: Thymosin beta-4 actin study

One vial labelled 10mg of TB-500, supplied as lyophilised (freeze-dried) powder. The mg value is the labelled amount in the vial, not a solution concentration.

For Research Use Only, for in vitro laboratory work. Not for human or animal consumption.

Yes. The linked source report for batch CP-TB500-06-04 is available in Batch documentation. Match it to the batch on the supplied vial.

A COA records analytical results for the submitted sample. It is not a clinical study or a guarantee of suitability for every experiment.

Pillar Research lists TB-500 10mg on this product page for Research Use Only. This strength is available to preorder. Orders dispatch by September 15. This is a dispatch estimate, not a delivery date.

Orders are placed online. For in-stock items, select the quantity and add to cart; for preorders, check the dispatch estimate before ordering.

TB-500 10mg is listed at A$119.99 per vial, in Australian dollars. The price is for this strength, not every variant.

Any applicable offer and shipping charges are shown in the order total before payment. Check the availability shown above before ordering.

Follow the storage conditions and expiry on the supplied label and any accompanying handling documentation. Keep the original container and batch identification.

If a temperature range or shelf life is missing, request it before use. A general product-page answer cannot establish stability after a laboratory preparation is made.